Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0001610717-26-000158 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 29, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
9,360
Total Value
$518,023.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Global Commercialization Officer | Common Stock | โ | Apr 27, 2026 | Exercise/Conversion | 3,120 | $33.62 | $104,894.40 | 57,520 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Apr 27, 2026 | Sale | 1,671 | $131.66 | $220,007.03 | 55,849 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Apr 27, 2026 | Sale | 1,049 | $132.88 | $139,387.76 | 54,800 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Apr 27, 2026 | Sale | 400 | $134.34 | $53,734.00 | 54,400 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Stock Option (Right to Buy) | Derivative | Apr 27, 2026 | Exercise/Conversion | 3,120 | $0.00 | $0.00 | 109,230 | Direct | โ | View Details |